Notal Vision
Notal Vision specializes in remote patient monitoring services for retinal diseases, utilizing AI-driven data interpretation to extend eye disease management from clinics to homes.
Services
Notal Vision provides remote patient monitoring services specifically for retinal diseases. Their services focus especially on extending the management of eye diseases from traditional clinical settings to patients' homes. To achieve this, they employ AI-driven data interpretation to support precision medicine in eye care.
Products
Notal Vision has developed several advanced tools for eye care, including ForeseeHome, a home monitoring device that facilitates early detection of changes in wet Age-related Macular Degeneration (AMD). The ForeseeHome device is both FDA-cleared and covered by Medicare for eligible patients. Additionally, Notal Vision is in the process of developing a home-based Optical Coherence Tomography (OCT) device intended for monitoring neovascular AMD. This device has received the Breakthrough Device Designation from the FDA.
Technological Innovations
Notal Vision pioneers in integrating AI-driven data interpretation into home-based eye disease management. By employing advanced technology, the company aims to improve the precision of eye care and provide better patient outcomes. Their approach includes using patient-operated diagnostics that allow for continuous and accurate monitoring of retinal diseases in the comfort of patients' homes.
Locations
Headquartered in Manassas, Virginia, Notal Vision also operates a research and development center based in Tel Aviv, Israel. These locations serve as the core facilities for the company's operations and innovation in the field of ophthalmology.